Rare diseases
Investigational molecules
Locations
Back to Belgium14 clinical trials in Kluisbergen, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
Efficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity
BelgiumStudy of the efficacy and safety of Eloralintide in adults with knee osteoarthritis and overweight or obesity
BelgiumA study to evaluate the effectiveness and safety of eloralintide in adults with obesity or overweight without type 2 diabetes.
BelgiumA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
BelgiumA study of brenipatide compared to placebo for the treatment of adults with alcohol use disorder
BelgiumA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
BelgiumStudy on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older
BelgiumStudy on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease
BelgiumStudy on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections
BelgiumWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
BelgiumA Study of Brenipatide Compared to Placebo in Adults with Moderate-to-Severe Alcohol Use Disorder
BelgiumBelgiumThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) prevention in older adults. Researchers are evaluating innovative vaccine approaches for these common respiratory pathogens.
Multiple trials are examining vaccine effectiveness and immune responses in adults over 60 years of age.
Research examining a novel influenza vaccine in both younger and older adult populations. The studies focus on safety assessment and immune system response evaluation.
Trials aim to establish optimal dosing while ensuring robust protection against influenza.
Clinical research targeting urinary tract infections (UTI), with particular attention to prevention through vaccination. Studies include both male and female participants aged 18-64.
The research focuses on developing preventive measures against common bacterial infections.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
